✦ LIBER ✦

Mo1062 Adalimumab Trough Levels in a Prospective Cohort of Crohn's Disease Patients

✍ Scribed by van der Woude, Christien J.; Deuring, J. Jasper; West, Rachel; Zelinkova, Zuzana; Peppelenbosch, Maikel P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P598 Adalimumab trough levels in a prosp

✍ van der Woude, C.J.; Bultman, E.; Deuring, J.; West, R.; Zelinkova, Z.; Peppelen 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

Predictors of dose escalation of adalimu

✍ E. Bultman; C. de Haar; A. van Liere-Baron; H. Verhoog; R. L. West; E. J. Kuiper 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Clinical Experience with Adalimumab in a

✍ Nichita, Cristina; Stelle, Marc; Vavricka, Stephan; El-Wafa Ali, Abdou; Ballaben 📂 Article 📅 2010 🏛 S. Karger AG 🌐 English ⚖ 143 KB

Tu1169 Correlation Between Adalimumab Tr

✍ Bodini, Giorgia; Savarino, Vincenzo; Dulbecco, Pietro; Assandri, Lorenzo; Bruzzo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 123 KB

P132 - Clinical experience with adalimum

✍ C.M. Nichita; M. Stelle; S. Vavricka; A.A. El Wafa; P. De Saussure; A. Straumann 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 47 KB

Adalimumab for Crohn's disease: Long-ter

✍ Peters, Charlotte P.; Eshuis, Emma J.; Toxopeüs, Florien M.; Hellemons, Merel E. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 496 KB